Mullein Leaf Extract

Mullein Leaf Extract is derived from the leaves of Verbascum thapsus, a biennial plant native to Europe, North Africa, and Asia. The extract is produced through aqueous or hydroalcoholic extraction of dried leaves, yielding a preparation rich in mucilage, saponins, flavonoids, and phenolic acids. It has a long history of traditional use in European herbal medicine, particularly for respiratory comfort.

For private-label brands, Mullein Leaf Extract offers a low-cost, heat-stable botanical active that integrates well into gummy and sachet formats. Its earthy herbal taste is manageable with flavouring systems, and its mucilaginous properties can contribute positively to gummy texture. Brands typically position it within respiratory wellness ranges, often alongside complementary botanicals like Ginger or Thyme.

Origin and history

Verbascum thapsus, commonly known as great mullein or common mullein, has been used in European folk medicine for centuries. The plant is native to Europe and Asia and has naturalised across North America. Traditional preparations included teas, tinctures, and poultices made from the leaves and flowers, valued for their soothing properties. The genus name Verbascum is thought to derive from the Latin barbascum, meaning "bearded," referring to the plant's hairy leaves.

Industrial production of Mullein Leaf Extract involves harvesting the leaves at peak flowering, drying them, and then extracting with water or ethanol-water mixtures. The extract is concentrated and spray-dried to a powder for use in dietary supplements. Modern manufacturing follows Good Manufacturing Practice (GMP) standards, with quality control focused on marker compounds such as verbascoside and aucubin. The ingredient is widely available from European botanical extract suppliers.

Scientific overview

Mullein Leaf Extract contains a complex mixture of bioactive compounds. The mucilage content (primarily polysaccharides) provides demulcent properties, forming a soothing film on mucous membranes. Saponins contribute to expectorant activity by thinning mucus secretions. Flavonoids including quercetin, luteolin, and apigenin offer antioxidant properties. Verbascoside, a phenylethanoid glycoside, is often used as a marker compound for standardisation.

Bioavailability of the active compounds varies. Mucilage acts locally in the gastrointestinal and respiratory tracts and does not require systemic absorption. Flavonoids and verbascoside are absorbed to varying degrees, with first-pass metabolism affecting their bioavailability. Standardised extracts typically contain 2-10% verbascoside, though non-standardised extracts are also common in traditional formulations.

From a manufacturing perspective, Mullein Leaf Extract is heat-stable and soluble in gummy formulations. Its low cost per serving (typically €0.01-0.03 per 500 mg dose) makes it an accessible botanical for private-label ranges. The earthy flavour profile requires masking with complementary flavours such as honey, lemon, or berry. The mucilaginous nature of the extract can improve gummy texture by contributing to chewability and mouthfeel.

Mullein Leaf Extract occupies a well-established position in the respiratory wellness category, one of the most familiar and commercially understood botanical segments across EU and US markets. Brands use it to create traditional herbal offerings that appeal to consumers seeking plant-based alternatives for seasonal wellness. It pairs naturally with other respiratory botanicals like Ginger, Thyme, and Echinacea, allowing for multi-ingredient formulations that differentiate on the shelf. The low cost tier makes it feasible for entry-level private-label ranges and high-volume SKUs.

From a formulation perspective, Mullein Leaf Extract presents few manufacturing challenges. It is heat-stable, soluble in gummy bases, and compatible with standard gummy processing temperatures. The earthy taste is manageable with flavouring systems, and the mucilaginous properties can be leveraged to improve gummy texture. Typical dosing ranges from 200 mg to 1500 mg per serving, with most commercial products using 300-500 mg per gummy. DAT confirms final dosage and format per project based on target market and regulatory review.

For pack copy, brands must exercise claim discipline. Mullein Leaf Extract has no EFSA-authorised health claims under Reg. 432/2012. EU positioning should rely on traditional herbal registration (THR) routes or co-formulated nutrients such as Vitamin C (for normal immune function) or Zinc (for normal immune system function). No disease claims, no "anti-inflammatory" language, and no "immune booster" without case-by-case review. DAT reviews claim strategy per project and confirms certification status per batch before final label claims.